BARDA supports development of oral radiation drug
by Zangani • 30 September 2011 • General News
WASHINGTON–(BUSINESS WIRE)–A drug that can be taken orally to treat internal contamination from radiation after a radiological attack will be developed under a new contract issued today by the U.S. Department of Health and Human Services’ Biomedical Advanced Research and Development Authority (BARDA). Under the contract, Nanotherapeutics Inc. of Alachua, Fla., will conduct studies to [...]
Read more →